Abbott Laboratories Stock CINNOBER BOAT
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
| Market Cap | 185B 161B 150B 138B 260B 17,668B 265B 1,773B 695B 8,811B 696B 681B 29,060B | P/E 2026 * |
30.7x | P/E 2027 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 210B 182B 170B 156B 294B 19,971B 299B 2,005B 785B 9,959B 787B 770B 32,849B | EV / Sales 2026 * |
4.17x | EV / Sales 2027 * | 3.78x |
| Free-Float |
86.16% | Yield 2026 * |
2.41% | Yield 2027 * | 2.56% |
Last Transcript: Abbott Laboratories
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 185B | |
| -1.68% | -1.68% | -4.71% | +1.64% | 111B | |
| -1.72% | -4.93% | +3.46% | +63.93% | 60B | |
| +2.63% | +9.46% | +43.51% | +59.34% | 53.9B | |
| -1.54% | +0.98% | -6.11% | -37.97% | 46.9B | |
| +0.61% | 0.00% | - | - | 34.22B | |
| -0.34% | +16.41% | +14.27% | -27.59% | 32.95B | |
| -1.65% | +2.26% | +44.57% | -8.12% | 24.49B | |
| -0.53% | -0.16% | +0.68% | +1.76% | 22.67B | |
| +0.50% | +1.49% | -8.71% | +5.81% | 21.75B | |
| Average | -0.39% | +5.19% | +10.87% | +7.35% | 45.31B | |
| Weighted average by Cap. | -0.44% | +4.29% | +8.38% | +12.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.3B 43.72B 40.82B 37.47B 70.65B 4,795B 71.88B 481B 188B 2,391B 189B 185B 7,887B | 54.65B 47.5B 44.34B 40.71B 76.76B 5,209B 78.09B 523B 205B 2,598B 205B 201B 8,568B |
| Net income | 6.25B 5.44B 5.08B 4.66B 8.79B 596B 8.94B 59.84B 23.44B 297B 23.49B 22.97B 981B | 7.92B 6.89B 6.43B 5.9B 11.13B 755B 11.32B 75.81B 29.69B 377B 29.76B 29.1B 1,242B |
| Net Debt | 24.17B 21B 19.61B 18B 33.94B 2,303B 34.53B 231B 90.55B 1,149B 90.77B 88.76B 3,789B | 21.42B 18.61B 17.38B 15.95B 30.08B 2,041B 30.6B 205B 80.25B 1,018B 80.44B 78.66B 3,358B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
